S D'Emidio

979 total citations
14 papers, 781 citations indexed

About

S D'Emidio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, S D'Emidio has authored 14 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in S D'Emidio's work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). S D'Emidio is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). S D'Emidio collaborates with scholars based in Italy and United States. S D'Emidio's co-authors include Francesco Graziano, Vincenzo Catalano, Paolo Giordani, Paolo Alessandroni, Daniele Santini, Anna Maria Baldelli, Mauro Magnani, Annamaria Ruzzo, Giuseppe Tonini and Alfredo Falcone and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S D'Emidio

14 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S D'Emidio Italy	8	452	267	265	162	144	14	781
Takako Yoshii Japan	8	579 1.3×	284 1.1×	218 0.8×	84 0.5×	195 1.4×	37	773
Akiko Kawano Nagatsuma Japan	12	381 0.8×	387 1.4×	153 0.6×	164 1.0×	101 0.7×	16	653
Salah-Eddin Al-Batran Germany	10	613 1.4×	441 1.7×	256 1.0×	64 0.4×	109 0.8×	30	828
Yuichi Mikamoto Japan	7	688 1.5×	318 1.2×	196 0.7×	77 0.5×	219 1.5×	10	852
Marta Martín-Richard Spain	17	483 1.1×	238 0.9×	190 0.7×	150 0.9×	100 0.7×	42	708
Yuezong Bai China	15	629 1.4×	402 1.5×	149 0.6×	248 1.5×	158 1.1×	60	987
Jaideep Sandhu United States	12	724 1.6×	213 0.8×	161 0.6×	149 0.9×	338 2.3×	29	929
Izuma Nakayama Japan	14	527 1.2×	450 1.7×	214 0.8×	123 0.8×	99 0.7×	108	820
G Nishimura Japan	14	287 0.6×	185 0.7×	196 0.7×	205 1.3×	131 0.9×	43	627

Countries citing papers authored by S D'Emidio

Since Specialization

Citations

This map shows the geographic impact of S D'Emidio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S D'Emidio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S D'Emidio more than expected).

Fields of papers citing papers by S D'Emidio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S D'Emidio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S D'Emidio. The network helps show where S D'Emidio may publish in the future.

Co-authorship network of co-authors of S D'Emidio

This figure shows the co-authorship network connecting the top 25 collaborators of S D'Emidio. A scholar is included among the top collaborators of S D'Emidio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S D'Emidio. S D'Emidio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Catalano, Vincenzo, Renato Bisonni, Francesco Graziano, et al.. (2012). A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 16(3). 411–419. 28 indexed citations

Catalano, Vincenzo, Bruno Vincenzi, Paolo Giordani, et al.. (2012). Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study. Gastric Cancer. 15(4). 419–426. 2 indexed citations

Catalano, Vincenzo, Valerio Sisti, Daniele Spada, et al.. (2012). Assessment of the 7th edition of the AJCC classification and a proposal of a new classification in patients with gastric cancer undergoing D2 gastrectomy.. Journal of Clinical Oncology. 30(15_suppl). 4084–4084. 1 indexed citations

Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Annals of Oncology. 23(1). 135–141. 88 indexed citations

Catalano, Vincenzo, Pasquale Mellone, Alfredo D’Avino, et al.. (2011). HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer. Histopathology. 58(5). 669–678. 20 indexed citations

Canestrari, Emanuele, Annamaria Ruzzo, Bruno Vincenzi, et al.. (2011). Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR.. Journal of Clinical Oncology. 29(15_suppl). 3635–3635. 1 indexed citations

Graziano, Francesco, Nadia Galluccio, Paola Lorenzini, et al.. (2011). Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer. Journal of Clinical Oncology. 29(36). 4789–4795. 145 indexed citations

Galluccio, Nadia, Annamaria Ruzzo, Emanuele Canestrari, et al.. (2011). C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC).. Journal of Clinical Oncology. 29(15_suppl). 4038–4038. 1 indexed citations

Graziano, Francesco, Emanuele Canestrari, Fotios Loupakis, et al.. (2010). Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan. The Pharmacogenomics Journal. 10(5). 458–464. 93 indexed citations

10.

Graziano, Francesco, Annamaria Ruzzo, Emanuele Canestrari, et al.. (2010). Host Genetic Variants in the IGF Binding Protein-3 Impact on Survival of Patients with Advanced Gastric Cancer Treated with Palliative Chemotherapy. Pharmacogenomics. 11(9). 1247–1256. 5 indexed citations

11.

Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. British Journal of Cancer. 100(6). 881–887. 158 indexed citations

12.

Ruzzo, Annamaria, Fotios Loupakis, Emanuele Canestrari, et al.. (2009). KRAS codon 61, 146 and BRAF V600E mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. CINECA IRIS Institutial research information system (University of Pisa). 20. 2 indexed citations

13.

Catalano, Vincenzo, Francesco Graziano, Daniele Santini, et al.. (2008). Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?. British Journal of Cancer. 99(9). 1402–1407. 72 indexed citations

14.

Perrone, Giuseppe, Pier Adelchi Ruffini, Vincenzo Catalano, et al.. (2008). Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. European Journal of Cancer. 44(13). 1875–1882. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact